Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ISRG NYSE:PATH NASDAQ:SYM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$429.59-3.2%$458.68$425.00▼$616.00$159.08B1.612.40 million shs2.77 million shsPATHUiPath$17.04-8.0%$11.99$9.38▼$18.74$9.83B1.0727.42 million shs62.33 million shsSYMSymbotic$63.73-5.1%$53.19$16.32▼$71.29$39.65B2.062.25 million shs1.80 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical-3.19%-5.03%-4.53%-16.11%-12.40%PATHUiPath-8.17%+32.11%+46.54%+37.82%+36.94%SYMSymbotic-5.08%+1.00%+30.35%+35.42%+174.22%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$429.59-3.2%$458.68$425.00▼$616.00$159.08B1.612.40 million shs2.77 million shsPATHUiPath$17.04-8.0%$11.99$9.38▼$18.74$9.83B1.0727.42 million shs62.33 million shsSYMSymbotic$63.73-5.1%$53.19$16.32▼$71.29$39.65B2.062.25 million shs1.80 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical-3.19%-5.03%-4.53%-16.11%-12.40%PATHUiPath-8.17%+32.11%+46.54%+37.82%+36.94%SYMSymbotic-5.08%+1.00%+30.35%+35.42%+174.22%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISRGIntuitive Surgical 2.59Moderate Buy$589.4337.21% UpsidePATHUiPath 2.06Hold$13.21-22.43% DownsideSYMSymbotic 2.17Hold$44.61-30.00% DownsideCurrent Analyst Ratings BreakdownLatest ISRG, SYM, and PATH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025ISRGIntuitive SurgicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)10/8/2025PATHUiPathWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)10/8/2025SYMSymboticWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)10/7/2025SYMSymboticBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageUnderweight$38.0010/7/2025ISRGIntuitive SurgicalEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetIn-Line$535.00 ➝ $450.0010/7/2025SYMSymboticBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageUnderweight$38.0010/2/2025PATHUiPathBMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Perform$12.50 ➝ $13.0010/2/2025SYMSymboticNorthcoast ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$65.0010/2/2025SYMSymboticNorthcoast ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$65.0010/1/2025ISRGIntuitive SurgicalThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$621.00 ➝ $567.0010/1/2025ISRGIntuitive SurgicalBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$571.00(Data available from 10/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISRGIntuitive Surgical$8.35B18.44$7.73 per share55.55$46.41 per share9.26PATHUiPath$1.43B6.33$0.03 per share610.22$3.33 per share5.12SYMSymbotic$1.82B20.65$0.03 per share2,473.69$0.67 per share95.12Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISRGIntuitive Surgical$2.32B$7.1759.9156.304.6628.51%14.56%12.93%10/21/2025 (Estimated)PATHUiPath-$73.69M$0.03567.83N/A6.851.35%1.28%0.83%12/4/2025 (Estimated)SYMSymbotic-$13.49M-$0.07N/A130.0613.01-0.38%-2.02%-0.47%11/17/2025 (Estimated)Latest ISRG, SYM, and PATH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/21/2025Q3 2025ISRGIntuitive Surgical$2.00N/AN/AN/A$2.41 billionN/A9/4/2025Q2 2026PATHUiPath$0.08$0.15+$0.07$0.02$347.36 million$361.73 million8/6/2025Q3 2025SYMSymbotic$0.03-$0.05-$0.08-$0.05$533.55 million$592.12 million7/22/2025Q2 2025ISRGIntuitive Surgical$1.93$2.19+$0.26$1.81$2.35 billion$2.44 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthISRGIntuitive SurgicalN/AN/AN/AN/AN/APATHUiPathN/AN/AN/AN/AN/ASYMSymboticN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioISRGIntuitive SurgicalN/A5.174.18PATHUiPathN/A2.752.75SYMSymboticN/A1.080.98Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISRGIntuitive Surgical83.64%PATHUiPath62.50%SYMSymboticN/AInsider OwnershipCompanyInsider OwnershipISRGIntuitive Surgical0.70%PATHUiPath23.19%SYMSymbotic0.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableISRGIntuitive Surgical15,638358.48 million355.97 millionOptionablePATHUiPath3,868531.02 million407.88 millionOptionableSYMSymbotic1,650590.49 million586.95 millionNot OptionableISRG, SYM, and PATH HeadlinesRecent News About These CompaniesSymbotic (NASDAQ:SYM) Upgraded to "Hold" at Wall Street ZenOctober 11 at 2:59 AM | americanbankingnews.comSymbotic (NASDAQ:SYM) Upgraded at Wall Street ZenOctober 11 at 2:57 AM | marketbeat.comSymbotic (NASDAQ:SYM) Shares Down 2.5% on Insider SellingOctober 11 at 2:10 AM | americanbankingnews.comDavid Ladensohn Sells 23,000 Shares of Symbotic (NASDAQ:SYM) StockOctober 10 at 7:42 PM | marketbeat.comHere's Why Symbotic Inc. (SYM) Fell More Than Broader MarketOctober 10 at 7:01 PM | zacks.comSymbotic (NASDAQ:SYM) Shares Down 5.1% - Here's What HappenedOctober 10 at 5:40 PM | marketbeat.comSymbotic Stock is Up 172% This Year—Here Is Why it's Not Done YetOctober 10 at 7:01 AM | 247wallst.comSymbotic Stock is Up 172% This Year—Here Is Why it's Not Done YetOctober 10 at 6:02 AM | 247wallst.comHere's Why Symbotic Inc. (SYM) Fell More Than Broader MarketOctober 9 at 7:16 PM | zacks.comSymbotic (NASDAQ:SYM) Stock Price Down 2.5% Following Insider SellingOctober 9 at 4:58 PM | marketbeat.comSymbotic Inc. (SYM) is Attracting Investor Attention: Here is What You Should KnowOctober 9 at 10:01 AM | zacks.comSymbotic (NASDAQ:SYM) Upgraded to Strong Sell at BarclaysOctober 9 at 7:28 AM | marketbeat.comWeiss Ratings Reiterates Hold (C-) Rating for Symbotic (NASDAQ:SYM)October 9 at 2:11 AM | marketbeat.comWhy I'm Taking A Step Back: Downgrading Symbotic To HoldOctober 8 at 8:23 PM | seekingalpha.comInsider Selling: Symbotic (NASDAQ:SYM) Director Sells 4,000 Shares of StockOctober 8 at 6:41 PM | marketbeat.comBarclays Initiates Coverage of Symbotic (SYM) with Underweight RecommendationOctober 8 at 3:21 PM | msn.comSymbotic: New Storage Platform Unlocks Growth PotentialOctober 8 at 7:03 AM | seekingalpha.comSymbotic (NASDAQ:SYM) Hits New 52-Week High - Here's WhyOctober 8 at 6:17 AM | marketbeat.comTyche Wealth Partners LLC Purchases New Position in Symbotic Inc. $SYMOctober 8 at 4:43 AM | marketbeat.comSymbotic initiated with an Underweight at BarclaysOctober 8 at 2:12 AM | msn.comWill Symbotic's (SYM) New Battery Technology Shift the Competitive Landscape in Warehouse Automation?October 7, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025The Fed Cut Rates: What Now for the S&P 500 and Equity Markets?By Thomas Hughes | September 18, 2025ISRG, TEAM, SFM Trade Well Below Highs With 30%+ UpsideBy Leo Miller | September 23, 2025Is Intuitive Surgical the Hidden Winner in Healthcare’s Weakness?By Gabriel Osorio-Mazilli | October 1, 2025The New Brain of Business: UiPath Is Creating an AI RevolutionBy Jeffrey Neal Johnson | October 2, 2025ISRG, SYM, and PATH Company DescriptionsIntuitive Surgical NASDAQ:ISRG$429.59 -14.17 (-3.19%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$428.35 -1.24 (-0.29%) As of 10/10/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.UiPath NYSE:PATH$17.04 -1.48 (-7.97%) Closing price 10/10/2025 03:59 PM EasternExtended Trading$16.54 -0.50 (-2.94%) As of 10/10/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric. It serves banking and financial services, healthcare, insurance, public sectors, manufacturing, retail, and telecom industries. The company was founded in 2005 and is headquartered in New York, New York.Symbotic NASDAQ:SYM$63.73 -3.41 (-5.08%) Closing price 10/10/2025 03:59 PM EasternExtended Trading$62.27 -1.46 (-2.30%) As of 10/10/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Symbotic Inc., an automation technology company, engages in developing technologies to improve operating efficiencies in modern warehouses. The company automates the processing of pallets and cases in large warehouses or distribution centers for retail companies. Its systems enhance operations at the front end of the supply chain. The company was founded in 2006 and is headquartered in Wilmington, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Gets Second $420 Target as CPO Win Boosts Outlook AST SpaceMobile's Big Win: Shares Soar on New Deal With Verizon Bassett Furniture: Buy Now, Sit Back, and Collect Dividends Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can Bargain Alert: DraftKings Is the Most Oversold It’s Ever Been Constellation Brands: Buffett’s $2.2B Bet May Have Hit Bottom How Gamers Are Powering Microsoft’s Next Wave of Growth Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
